
Retatrutide 10mg Research Vial
Retatrutide 10mg is a lyophilised research peptide supplied as a single, sealed vial for controlled in vitro studies of metabolic signalling.
Retatrutide 40mg is a lyophilised research peptide supplied in a sealed vial for higher-volume in vitro metabolic studies.

Retatrutide 40mg is a lyophilised research peptide supplied in a sealed vial for higher-volume in vitro metabolic studies.
Price shown is for a single 40mg vial. The final amount is confirmed at checkout. Need a different amount? Send an inquiry.
Retatrutide 40mg is a lyophilised research peptide supplied in a sealed vial for higher-volume in vitro metabolic studies. This 40mg strength is aimed at labs that require a greater reserve of material for repeated or larger-scale experiments. Retatrutide is studied as a peptide acting at GLP-1, GIP and glucagon receptors in metabolic research models. The vial contains freeze-dried powder with a stated 40mg content, sealed to protect the material during storage. A batch-specific analytical report accompanies the listing and records the measured characteristics of the lot, including CAS 2381089-83-2. The product is offered strictly for laboratory research and makes no claim about effects in people. This listing is for the 40mg vial. The material is identified by CAS number 2381089-83-2.
| Labelled amount | 40mg |
|---|---|
| Form | Lyophilised powder |
| CAS number | 2381089-83-2 |
| Intended use | In vitro laboratory research |
Every vial is supplied with an analytical report prepared for its own batch. The report records identity and purity results for the submitted sample. Match the batch identifier on the report to the vial you receive before use.
Retatrutide 40mg is a lyophilised research peptide supplied in a sealed vial for higher-volume in vitro metabolic studies. It is supplied as a lyophilised, sealed research vial and is not a medicine.
The vial is labelled with a nominal 40mg of material. The figure is the stated content of the vial, not a solution concentration, and should be checked against the batch documentation before use.
Yes. Each listing links to the analytical report prepared for the specific batch. The report records identity and purity results for the submitted sample and should be matched to the vial you receive.
It arrives as a freeze-dried powder in a sealed vial. Keep the container closed and follow the storage conditions printed on the label and any handling sheet supplied with the lot.
No. AthloPep supplies this material for in vitro laboratory research only. It is not for human or animal consumption and no therapeutic use is implied.
The listed unit price for this vial is $217.8. Prices are shown in US dollars and the final amount is confirmed on the checkout page before payment.

Retatrutide 10mg is a lyophilised research peptide supplied as a single, sealed vial for controlled in vitro studies of metabolic signalling.

Retatrutide 15mg is a lyophilised research peptide supplied as a single, sealed vial for metabolic receptor studies in vitro.

Retatrutide 20mg is a lyophilised research peptide in a sealed vial, intended for laboratory studies of metabolic and receptor pathways.

Retatrutide 30mg is a sealed, lyophilised research vial for in vitro work on metabolic receptor signalling.
Tell us what you need. An email address is required so we can reply.